文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症创伤与烧伤

单核细胞大小不均一性可区分脓毒症与无菌性炎症,但不能预测危重外科/创伤患者的死亡率:一项二次前瞻性分析

Monocyte Anisocytosis Can Discriminate Between Sepsis and Sterile Inflammation, but not Mortality, in Critically Ill Surgical/Trauma Patients: A Secondary Prospective Analysis.
PubMed 文献 · Crit Care Explor · 2025-09-09
一句话结论在外科/创伤ICU患者中,入ICU时单核细胞分布宽度(MDW)>22.0可区分脓毒症与无菌性炎症(灵敏度90%、特异度78%),但不能判别院内、30天或90天死亡率。

本研究为三项前瞻性观察性临床研究的二次分析,单中心ICU,纳入238例参与者:107例脓毒症患者、80例危重非脓毒症(CINS)患者和51例健康对照。入ICU时MDW在脓毒症与CINS患者间差异显著(26.4 vs 20.1,p<0.001),受试者工作特征曲线下面积为0.85(95%CI 0.79-0.91;p<0.001)。MDW>22.0识别脓毒症的灵敏度为90%、特异度为78%,但不能判别院内、30天或90天死亡率。作者结论认为,在外科/创伤ICU患者中MDW可区分脓毒症与非脓毒症性炎症,但对死亡率的预测能力较弱。

要点

  • 入ICU时MDW在脓毒症患者为26.4(IQR 23.5-30.8),在危重非脓毒症患者为20.1(IQR 17.9-21.9),差异显著(p<0.001)。
  • MDW判别脓毒症的AUC为0.85(95%CI 0.79-0.91;p<0.001),入ICU时MDW>22.0的灵敏度为90%、特异度为78%。
  • MDW不能判别院内、30天或90天死亡率。
  • 研究为单中心小样本二次分析,未纳入降钙素原、C反应蛋白和白细胞介素-6等其他相关生物标志物。
  • 作者结论:在外科/创伤ICU患者中,MDW可区分脓毒症与非脓毒症性炎症,但对死亡率的预测能力较弱。

适用人群与场景

  • 纳入外科/创伤ICU患者:107例入ICU并判定为脓毒症的患者、80例危重非脓毒症(CINS)且有脓毒症风险的患者,以及51例健康对照参与者。
  • 场景为单中心ICU,血样在入ICU时及ICU住院期间间隔采集。

诊断标准与关键阈值

  • 入ICU时MDW>22.0用于识别脓毒症,灵敏度90%、特异度78%。
  • MDW判别脓毒症的AUC为0.85(95%CI 0.79-0.91;p<0.001)。

研究设计与关键结果

  • 研究设计为三项前瞻性观察性临床研究的二次分析,单中心ICU,共纳入238例参与者(107例脓毒症、80例CINS、51例健康对照)。
  • 入ICU时MDW在脓毒症组为26.4(IQR 23.5-30.8),在CINS组为20.1(IQR 17.9-21.9),两组差异显著(p<0.001)。
  • MDW判别脓毒症的AUC为0.85(95%CI 0.79-0.91;p<0.001);入ICU时MDW>22.0识别脓毒症的灵敏度为90%、特异度为78%。
  • MDW不能判别院内、30天或90天死亡率。

证据类型、等级与局限

  • 证据类型:三项前瞻性观察性临床研究的二次分析。
  • 局限:单中心小样本;分析未纳入降钙素原、C反应蛋白和白细胞介素-6等其他相关生物标志物;缺失值填补采用线性混合效应模型,存在模型设定错误和违反随机缺失假设的风险。

对床旁实践的改变

  • 在外科/创伤ICU患者中,入ICU时MDW>22.0可帮助区分脓毒症与无菌性炎症(灵敏度90%、特异度78%),但MDW不能用于判别院内、30天或90天死亡率。
  • 作者结论认为,MDW可区分脓毒症与非脓毒症性炎症,但对死亡率的预测能力较弱。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES BACKGROUND: Monocyte anisocytosis (monocyte distribution width [MDW]) has been previously validated to predict sepsis and outcome in patients presenting in the emergency department and mixed-population ICUs. Determining sepsis in a critically ill surgical/trauma population is often difficult due to concomitant inflammation and stress. We examined whether MDW could identify sepsis among patients admitted to a surgical/trauma ICU and predict clinical outcome.

DESIGN: Secondary analysis of three prospective observational clinical studies.

SETTING: Single institution ICU.

PATIENTS/SUBJECTS: Two hundred thirty-eight participants were included in this study: 107 patients who were admitted to the ICU and adjudicated to have sepsis, 80 patients who were considered critically ill nonseptic (CINS), and 51 healthy control participants.

INTERVENTIONS: MDW was measured among hospitalized patients admitted to the ICU with the diagnosis of sepsis or CINS patients at risk of developing sepsis. Blood samples were collected at admission and at intervals during ICU admission.

MEASUREMENTS AND MAIN RESULTS: MDW significantly differed between septic and CINS patients on ICU admission (26.4, interquartile range [IQR, 23.5-30.8] vs. 20.1 [IQR, 17.9-21.9]; p < 0.001) and could discriminate with an area under the receiver operating characteristic curve of 0.85 (95% CI, 0.79-0.91; p < 0.001). An MDW of greater than 22.0 at admission to the ICU could identify sepsis with a 78% specificity and a 90% sensitivity but could not discriminate in-hospital, 30-day, or 90-day mortality.

LIMITATIONS: Small sample size from a single institution. Our analysis did not include other relevant biomarkers such as procalcitonin, C-reactive protein, and interleukin-6. In the imputation of missing values, linear mixed-effect models were used, risking model misspecification and the violation of the missing-at-random assumption.

CONCLUSIONS: Among surgical/trauma ICU patients, MDW can discriminate between sepsis and nonseptic inflammation, but it is a weak predictor of mortality.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Hernández-Ríos M, Wu R, Polcz VA, et al. Monocyte Anisocytosis Can Discriminate Between Sepsis and Sterile Inflammation, but not Mortality, in Critically Ill Surgical/Trauma Patients: A Secondary Prospective Analysis. Crit Care Explor. 2025. PMID: 40924914. doi:10.1097/CCE.0000000000001309

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。